Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 769–792 of 1,734 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: work therapy Clear all

Conditions: Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III, Breast Cancer Stage I
Interventions: Pencil Beam Scanning Proton Therapy; Radiation
Lead sponsor: Covenant Health Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Vasomotor Symptoms Associated With Menopause, Hot Flashes
Interventions: Elinzanetant (BAY3427080), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 628 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 36
States / cities: Mobile, Alabama • Mesa, Arizona • Garden Grove, California + 30 more

Conditions: Chronic Pain
Interventions: Occupational Therapy, Occupational Therapy +Virtual Reality; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Glioma, Brain Tumor, Primary
Interventions: CogMed®; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Heart Failure, Cardiogenic Shock, Congenital Heart Disease, Cardiomyopathies
Interventions: Cardiohelp device (VA-ECMO), Heparin, Bivalirudin; Device · Drug
Lead sponsor: Stanford University; Other
Eligibility: 0 Years to 16 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 5
States / cities: Palo Alto, California • New York, New York • Durham, North Carolina + 2 more

Conditions: Treatment Resistant Depression
Interventions: Discontinuation of serotonergic antidepressants, Continuation of serotonergic medications; Other
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Aging Well, Dementia, Telemedicine
Interventions: Music Therapy Telehealth, Non-Collaborative Social Work Telehealth, Collaborative Social Work Telehealth; Behavioral
Lead sponsor: Alaine E Hernandez, PhD; Other
Eligibility: 65 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Lexington, Kentucky • St Louis, Missouri

Conditions: Chronic Hepatitis C Virus
Interventions: SIMpill device; Device
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Locally Advanced Laryngeal Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Interventions: Toripalimab, Carboplatin, Cisplatin, Paclitaxel, Radiation Therapy; Drug · Radiation
Lead sponsor: Matthew Spector; Other
Eligibility: 18 Years and older
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Substance Use Disorders
Interventions: Modified Family Talk, Control-like parameter estimation; Other
Lead sponsor: Brown University; Other
Eligibility: 12 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Pawtucket, Rhode Island

Conditions: Depression, Postpartum, Labor Pain
Interventions: CSE, Epidural, Bupivacaine / fentaNYL; Procedure · Drug
Lead sponsor: Grace Lim, MD, MS; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Alzheimer Disease, Primary Progressive Aphasia, Mild Cognitive Impairment
Interventions: repetitive transcranial magnetic stimulation (rTMS); Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 90 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Breast Cancer
Interventions: Relaxation Program, Questionnaires, Saliva Testing; Other · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 681 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Care Transitions, Dementia
Interventions: CAPABLE Transitions, Home Health Agency Care; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 65 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Autism Spectrum Disorder
Interventions: Individual Cognitive Behavioral Therapy, Standard Community Treatment; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 6 Years to 10 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Labor Pain
Interventions: Virtual Reality; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: PTSD, Alcohol; Use, Problem
Interventions: Seeking Safety + Signs of Safety toolkit, Treatment as usual; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Melanoma Stage III, Melanoma Stage IV
Interventions: Nivolumab, BMS-986205, Ipilimumab; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Pain
Interventions: Transcutaneous Electrical Nerve Stimulation (TENS); Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: New Haven, Connecticut

Conditions: Psoriasis, Atopic Dermatitis
Interventions: In situ cutaneous microdevice, Triamcinolone, 5-Fluorouracil, Calcipotriene, Tapinarof, Crisaborole, Tacrolimus, Adalimumab, Etanercept, Certolizumab, Infliximab, Secukinumab, Ixekizumab, Apremilast, Risankizumab, Ustekinumab, Hydroxychloroquine, Methotrexate, Mycophenolate, Azathioprine, Chloroquine, Cyclosporine, Tofacitinib, Deucravacitinib, Dupilumab, Tralokinumab, Guselkumab, Tildrakizumab, Baractinib, Abrocitinib, Upadacitinib, Lebrikizumab, Nemolizumab, Ruxolitinib, Bimekizumab, Roflumilast; Device · Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Acute Illness
Interventions: Care Project for Hospitalized Elders & Family Caregivers, Comparison Group; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 21 Years and older
Enrollment: 421 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Bronchopulmonary Dysplasia, Very Low Birth Weight Infant, Prematurity
Interventions: Enrollment; Other
Lead sponsor: Christiana Care Health Services; Other
Eligibility: 1 Month to 7 Months
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Sleep Insufficiency
Interventions: Personalized Trial ABCCBA, Personalized Trial CBAABC; Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 40 Years to 60 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Labor Pain, Tocophobia
Interventions: Mind in Labor (MIL): Working with Pain in Childbirth, Treatment as usual (TAU); Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Female only
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy

A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause

Virtual Reality, Debriefing and Chronic Pain

Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Antidepressant Discontinuation in Treatment Resistant Depression

Music Therapy and Social Work Telehealth for Older Adult Well-Being

SIMpill Medication Dispensing Device in the Treatment of HCV

Window of Opportunity in Preserving Laryngeal Function Trial

Substance Use Prevention for Youth With Parents in Recovery

CSE v. Epidural for Postpartum Depression

Network Modulation in Alzheimer's Disease

Relaxation for Women With Breast Cancer Undergoing Radiotherapy

CAPABLE Transitions: A Home Health-Based Intervention for the Hospital or Post-Acute Care Facility-to-Home Transition

Schema, Emotion and Behavior-Based Therapy for School Children

Virtual Reality Analgesia in Labor: The VRAIL Pilot Study

Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma

A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma

Transcutaneous Electrical Nerve Stimulation (TENS) for Intrauterine Device (IUD) Insertion Pain

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Improving Outcomes of Hospitalized Elders and Caregivers

Work of Breathing in Premature Infants at Discharge

A Personalized Mind-Body Intervention (MBI) for Improving Sleep Among Women Working in Healthcare

Prenatal Education About Reducing Labor Stress (PEARLS)